Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| 10-Q | 8-K | 8-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
Interest income: |
Interest income on loans | 36.5 | 32.8 | 29.9 | 27.3 | 22.7 | 24.2 | 27.0 | 24.5 |
Interest income on investments | 3.0 | | | 2.3 | 1.6 | 1.3 | 1.2 | 1.1 |
| 40.1 | 36.6 | 34.3 | 30.5 | 24.6 | 25.8 | 28.4 | 25.8 |
Interest expense: |
Interest on deposits | 5.5 | | | 1.1 | 0.9 | 1.0 | 1.1 | 1.5 |
Interest on borrowings | 0.3 | | | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| 9.8 | 3.3 | 2.3 | 1.3 | 1.1 | 1.1 | 1.3 | 1.7 |
Net interest income | 30.3 | 33.3 | 32.0 | 29.2 | 23.5 | 24.7 | 27.1 | 24.1 |
Net interest income after provision for loan losses | 30.3 | 33.3 | 32.0 | 29.2 | 23.5 | 24.7 | 27.1 | 24.1 |
Other non-interest income | 3.4 | 0.3 | 0.2 | 3.7 | 3.4 | 3.5 | 5.4 | 3.3 |
Total non-interest income | 3.4 | 0.3 | 0.2 | 3.7 | 3.4 | 3.5 | 5.4 | 3.3 |
Non-interest expenses | 21.0 | 21.2 | 20.7 | 21.8 | 18.2 | 18.0 | 16.4 | 16.6 |
Pre-tax income before non-recurring items | 12.3 | 13.4 | 13.0 | 10.6 | 5.4 | 12.8 | 18.5 | 13.8 |
Non-recurring items | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | -0.5 |
Pre-tax income | 12.3 | 13.5 | 13.0 | 10.6 | 5.4 | 12.8 | 18.5 | 14.3 |
Income taxes | 2.5 | 2.7 | 2.6 | 2.1 | 1.0 | 2.6 | 3.4 | 2.9 |
Tax rate | 20.4% | 19.9% | 19.9% | 20.0% | 19.1% | 20.1% | 18.5% | 20.1% |
Net income | 9.8 | 10.8 | 10.4 | 8.5 | 4.4 | 10.2 | 15.1 | 11.4 |
Net margin | 29.0% | 32.1% | 32.4% | 25.7% | 16.4% | 36.3% | 46.3% | 41.6% |
|
Basic EPS | $1.22 | $1.33 | $1.29 | $1.04 | $0.53 | $1.22 | $1.80 | $1.35 |
Diluted EPS | $1.21 | $1.32 | $1.28 | $1.03 | $0.53 | $1.21 | $1.79 | $1.34 |
|
Shares outstanding (basic) | 8.0 | 8.1 | 8.1 | 8.1 | 8.3 | 8.4 | 8.4 | 8.4 |
Shares outstanding (diluted) | 8.1 | 8.2 | 8.2 | 8.2 | 8.3 | 8.4 | 8.4 | 8.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|